TriangleFOR PATIENTS · SOURCE READING
Treatment Option Overview
Source: Childhood Pheochromocytoma and Paraganglioma Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: July 21, 2022 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Continue within this section
Key Points →There are different types of treatment for children with pheochromocytoma or paraganglioma. →Children with pheochromocytoma or paraganglioma should have their treatment planned by a team of doctors who are experts in treating childhood cancer. →Four types of standard treatment are used: →New types of treatment are being tested in clinical trials. →Treatment of pheochromocytoma and paraganglioma may cause side effects. →Patients may want to think about taking part in a clinical trial. →Patients can enter clinical trials before, during, or after starting their cancer treatment. →Follow-up tests may be needed. →
Preserved source evidence · Independent clinical review pending · Not medical advice